MiR423-5p as a circulating biomarker for heart failure

Area of Science:

• Biomarkers
• Cardiovascular Research
• Molecular Diagnostics

Background:

• Aberrant circulating microRNA (miRNA) expression is linked to various diseases.
• Investigating circulating miRNAs as potential biomarkers for heart failure (HF) is crucial.

Purpose of the Study:

• To determine if miRNAs can differentiate heart failure (HF) patients from healthy controls.
• To assess if miRNAs can distinguish HF from non-HF causes of dyspnea.

Main Methods:

• Plasma miRNA expression profiling using miRNA arrays.
• Validation in a larger cohort including healthy controls, HF patients, and non-HF dyspnea patients.
• Receiver-operator characteristics (ROC) curve analysis for diagnostic accuracy.

Main Results:

• miR423-5p was specifically enriched in the blood of HF patients.
• ROC analysis indicated miR423-5p as a significant diagnostic predictor for HF (AUC=0.91, P<0.001).
• Five additional miRNAs showed elevated levels in HF, with slight increases also observed in non-HF dyspnea.

Conclusions:

• Six circulating miRNAs were identified as elevated in heart failure (HF) patients.
• miR423-5p demonstrated the strongest association with the clinical diagnosis of HF.
• These circulating miRNAs represent promising candidate biomarkers for HF detection.